A phase IIa study of novel maturation inhibitor GSK2838232 in HIV patients

Authors
Category Primary study
JournalTopics in Antiviral Medicine
Year 2019
This article has no abstract
Epistemonikos ID: 4fd6f3519e6121880dc9f2fb24a69ae1ead2d6f6
First added on: Feb 12, 2025